ERD

Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

High-Throughput Analysis of Neutrophil Extracellular Trap Levels in Subtypes of People with Type 1 Diabetes

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

NET Proteome in Established Type 1 Diabetes Is Enriched in Metabolic Proteins

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Heterogeneity and endotypes in type 1 diabetes mellitus

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Monitoring beta cell survival after intrahepatic islet transplantation using dynamic exendin PET imaging: a proof-of-con...

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Coxsackievirus infection induces direct pancreatic β-cell killing but poor anti-viral CD8+ T-cell responses

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

In vitro beta-cell killing models using immune cells and human pluripotent stem cell-derived islets: Challenges and oppo...

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

IL-2-based approaches to Treg enhancement

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Gene expression signature predicts rate of type 1 diabetes progression

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Tryptophan metabolism promotes immune evasion in human pancreatic β cells

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Family Structure is Associated with Mental Health and Attention Deficit (Hyperactivity) Disorders in Adolescents with Ty...

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

EndoC-βH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

IFNɣ but not IFNα increases recognition of insulin defective ribosomal product-derived antigen to amplify islet autoim...

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Epitope-based precision immunotherapy of Type 1 diabetes

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates TNF-α-induced human beta cell dysfunction and death

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Angiotensin I-converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Pancreatic Islet Cells Response to IFNγ Relies on Their Spatial Location within an Islet

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Unveiling nanoscale optical signatures of cytokine-induced β-cell dysfunction

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Every islet matters: improving the impact of human islet research

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Coxsackievirus and type 1 diabetes: diabetogenic mechanisms and implications for prevention

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trials

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

The extent and magnitude of islet T cell infiltration as powerful tools to define the progression to type 1 diabetes

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action ...

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

RedRibbon: A new rank-rank hypergeometric overlap for gene and transcript expression signatures

Project: INNODIA

Updated at: 28-02-2024

Show more information

Project acronym INNODIA

Resources

Selected filters:

Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells

High-Throughput Analysis of Neutrophil Extracellular Trap Levels in Subtypes of People with Type 1 Diabetes

NET Proteome in Established Type 1 Diabetes Is Enriched in Metabolic Proteins

Heterogeneity and endotypes in type 1 diabetes mellitus

Monitoring beta cell survival after intrahepatic islet transplantation using dynamic exendin PET imaging: a proof-of-con...

Coxsackievirus infection induces direct pancreatic β-cell killing but poor anti-viral CD8+ T-cell responses

In vitro beta-cell killing models using immune cells and human pluripotent stem cell-derived islets: Challenges and oppo...

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes

Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial

IL-2-based approaches to Treg enhancement

Gene expression signature predicts rate of type 1 diabetes progression

Tryptophan metabolism promotes immune evasion in human pancreatic β cells

The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes

Family Structure is Associated with Mental Health and Attention Deficit (Hyperactivity) Disorders in Adolescents with Ty...

EndoC-βH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion

IFNɣ but not IFNα increases recognition of insulin defective ribosomal product-derived antigen to amplify islet autoim...

Epitope-based precision immunotherapy of Type 1 diabetes

Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates TNF-α-induced human beta cell dysfunction and death

Angiotensin I-converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors

Pancreatic Islet Cells Response to IFNγ Relies on Their Spatial Location within an Islet

Unveiling nanoscale optical signatures of cytokine-induced β-cell dysfunction

Every islet matters: improving the impact of human islet research

Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?

Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)

Coxsackievirus and type 1 diabetes: diabetogenic mechanisms and implications for prevention

Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trials

The extent and magnitude of islet T cell infiltration as powerful tools to define the progression to type 1 diabetes

Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators

The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action ...

RedRibbon: A new rank-rank hypergeometric overlap for gene and transcript expression signatures